查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532825

细胞和基因治疗製造服务市场，按治疗类型、按细胞类型、按服务类型、按最终用户、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Cell and Gene Therapy Manufacturing Services Market, By Therapy Type, By Cell Type, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，细胞和基因治疗製造服务市场规模为 59.77 亿美元，2024 年至 2032 年复合年增长率为 17.2%。

细胞与基因治疗製造服务市场-市场动态

遗传性疾病和癌症的日益普及推动了对细胞和基因治疗製造服务的需求

遗传性疾病和癌症的盛行率日益增加，大大推动了对细胞和基因治疗製造服务的需求。例如，美国国家癌症研究所报告称，预计 2024 年仅美国就会新增近 190 万癌症病例，凸显了对先进治疗解决方案的迫切需求。同样，世界卫生组织指出，全球约有二十分之一的人患有遗传性疾病，增加了对专门治疗的需求。最近在这一领域的投资引人注目，美国国立卫生研究院去年为基因疗法研究拨款超过 10 亿美元。此外，诺华（Novartis）和蓝鸟生物（Bluebird Bio）等领先公司已经扩大了其製造能力，以满足对这些尖端治疗不断增长的需求，这反映出人们越来越关注透过创新疗法改善患者的治疗结果。

细胞和基因治疗製造服务市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 17.2% 左右的复合年增长率成长

根据治疗类型细分，预计基因治疗将在 2023 年显示最大的市场份额

根据细胞类型细分，自体细胞是2023年的主导类型

根据服务类型细分，合约开发和製造组织（CDMO）是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

细胞与基因治疗製造服务市场-細項分析：

全球细胞和基因治疗製造服务市场根据治疗类型、细胞类型、服务类型、最终用户和地区进行细分。

根据治疗类型，市场分为两类：细胞治疗和基因治疗。细胞疗法专注于用于治疗用途的细胞的生产和操作，而基因疗法则涉及开发改变遗传物质以治疗疾病的疗法。

市场依细胞类型分为两类：自体细胞和异体细胞。自体细胞来自患者自身，确保了相容性，而同种异体细胞则来自捐赠者，具有更广泛的应用潜力。

细胞和基因治疗製造服务市场 - 地理洞察

北美，尤其是美国，由于其先进的研究基础设施、大量资金和强大的专业製造设施网路而引领市场。在欧洲，德国和英国等国家也是重要的参与者，受益于强有力的监管框架以及生物技术公司与研究机构之间日益加强的合作。同时，亚太地区正在迅速崛起，中国和日本等国家大力投资生物技术创新并扩大其製造能力。例如，中国最近在基因治疗基础设施上投资了 5 亿美元，这反映出它越来越注重成为该领域的主要参与者。

细胞与基因疗法製造服务市场-竞争格局：

Lonza、Catalent 和 WuXi AppTec 等主要参与者凭藉广泛的製造能力和全球影响力占据市场主导地位，提供从细胞处理到基因编辑的一系列服务。这些公司得到了对尖端技术和战略合作伙伴关係的大量投资的支持。例如，龙沙与诺华合作提高CAR-T细胞疗法的生产能力，凸显了深化产业联盟的趋势。新兴生物技术公司和合约製造组织 (CMO) 也发挥着至关重要的作用，提供专业服务并推动创新。竞争环境的特点是技术不断进步、监管适应以及对可扩展和高效製造解决方案的重视。

最新进展：

2024年5月，ProPharma与PBL合作推出了细胞工厂盒（CF Box），这是一种全自动封闭式细胞工厂设备，专为细胞和基因疗法（CGT）的生产而设计。 CF Box 有助于在 D 级 (ISO8) 或受控非机密环境中分散製造各种 CGT。

2024 年 5 月，百时美施贵宝与 Cellares 签署了价值 3.8 亿美元的协议，生产 CAR T 细胞疗法，突显了对外包细胞和基因疗法製造服务的需求不断增长。 Cellares 计划扩大在美国、欧洲和日本的自动化製造工厂。

目录

第一章：细胞与基因治疗製造服务市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗类型分類的细胞和基因治疗製造服务市场片段
    • 按细胞类型分類的细胞和基因治疗製造服务市场片段
    • 按服务类型分類的细胞和基因治疗製造服务市场片段
    • 最终用户的细胞和基因治疗製造服务市场片段
    • 按国家/地区分類的细胞和基因治疗製造服务市场片段
    • 按地区分類的细胞和基因治疗製造服务市场片段
  • 竞争洞察

第 3 章：细胞和基因治疗製造服务主要市场趋势

  • 细胞和基因治疗製造服务市场驱动因素
    • 市场驱动因素的影响分析
  • 细胞和基因治疗製造服务市场限制
    • 市场限制影响分析
  • 细胞和基因治疗製造服务市场机会
  • 细胞和基因治疗製造服务市场未来趋势

第 4 章：细胞与基因治疗製造服务业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：细胞与基因治疗製造服务市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：细胞与基因疗法製造服务市场格局

  • 2023 年细胞和基因治疗製造服务市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：细胞和基因治疗製造服务市场 - 按治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 细胞疗法
    • 基因治疗

第 8 章：细胞和基因治疗製造服务市场 - 按细胞类型

  • 概述
    • 按电池类型分類的细分市场份额分析
    • 自体细胞
    • 同种异体细胞

第 9 章：细胞和基因治疗製造服务市场 - 按服务类型

  • 概述
    • 按服务类型分類的细分市场占有率分析
    • 合约开发与製造组织 (CDMO)
    • 合约研究组织（CRO）
    • 製造技术解决方案

第 10 章：细胞和基因治疗製造服务市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • 学术机构
    • 研究机构

第 11 章：细胞和基因疗法製造服务市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 细胞和基因治疗製造服务北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（按电池类型）
    • 北美市场规模和预测（按服务类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 细胞和基因治疗製造服务欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模和预测（按电池类型）
    • 欧洲市场规模和预测（按服务类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 细胞和基因治疗製造服务亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模和预测（按电池类型）
    • 亚太地区市场规模与预测（按服务类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 细胞和基因治疗製造服务拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模和预测（按电池类型）
    • 拉丁美洲市场规模和预测（按服务类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 细胞和基因治疗製造服务中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模和预测（按治疗类型）
    • 中东和非洲市场规模及预测（按电池类型）
    • 中东和非洲市场规模及预测（按服务类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 细胞和基因治疗製造服务产业

  • 竞争仪表板
  • 公司简介
    • Adaptimmune Therapeutics plc
    • Bluebird Bio, Inc.
    • Catalent, Inc.
    • Celyad Oncology SA
    • Charles River Laboratories International, Inc.
    • Gene Therapy Research Group
    • Kiadis Pharma NV
    • Lonza Group AG
    • MaxCyte, Inc.
    • Miltenyi Biotec GmbH
    • Orchard Therapeutics plc
    • Rocket Pharmaceuticals, Inc.
    • Sangamo Therapeutics, Inc.
    • Sarepta Therapeutics, Inc.
    • TCR2 Therapeutics Inc.
    • WuXi AppTec
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3413

REPORT HIGHLIGHT

Cell and Gene Therapy Manufacturing Services Market size was valued at USD 5,977 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

The Cell and Gene Therapy Manufacturing Services Market encompasses specialized services for the production of cell and gene therapies, which are revolutionary treatments targeting genetic disorders and various diseases. The rising prevalence of genetic disorders and cancer, coupled with advancements in personalized medicine, is fueling the market's expansion. However, challenges such as high production costs and complex regulatory requirements act as significant restraints. Opportunities are emerging in the form of increased investments in research and development, with global funding for cell and gene therapies having surged by approximately 30% in the past year. Additionally, partnerships between biotech firms and contract manufacturing organizations (CMOs) are on the rise, aiming to streamline production processes and enhance scalability.

Cell and Gene Therapy Manufacturing Services Market- Market Dynamics

Growing Prevalence of Genetic Disorders and Cancer Fuels Need for Cell and Gene Therapy Manufacturing Services

The increasing prevalence of genetic disorders and cancer is significantly driving the demand for Cell and Gene Therapy Manufacturing Services. For instance, the National Cancer Institute reports that nearly 1.9 million new cancer cases were expected in the U.S. alone in 2024, underscoring the urgent need for advanced therapeutic solutions. Similarly, the World Health Organization notes that genetic disorders affect about 1 in 20 people globally, amplifying the need for specialized therapies. Recent investments in this field have been notable, with the National Institutes of Health allocating over $1 billion in grants for gene therapy research in the past year. Additionally, leading companies like Novartis and Bluebird Bio have expanded their manufacturing capabilities to meet the rising demand for these cutting-edge treatments, reflecting a growing focus on improving patient outcomes through innovative therapies.

Cell and Gene Therapy Manufacturing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Therapy Type segmentation, Gene Therapy was predicted to show maximum market share in the year 2023

Based on Cell Type segmentation, Autologous Cells was the leading type in 2023

Based on Service Type segmentation, Contract Development and Manufacturing Organization (CDMO) was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell and Gene Therapy Manufacturing Services Market- Segmentation Analysis:

The Global Cell and Gene Therapy Manufacturing Services Market is segmented based on Therapy Type, Cell Type, Service Type, End-User, and Region.

The market is divided into two categories based on Therapy Type: Cell Therapy and Gene Therapy. Cell Therapy focuses on the production and manipulation of cells for therapeutic use, while Gene Therapy involves the development of treatments that alter genetic material to address diseases.

The market is divided into two categories based on Cell Type: Autologous Cells and Allogeneic Cells. Autologous Cells are derived from the patient's own body, ensuring compatibility, while Allogeneic Cells are sourced from donors and offer broader application potential.

Cell and Gene Therapy Manufacturing Services Market- Geographical Insights

North America, particularly the United States, leads the market due to its advanced research infrastructure, substantial funding, and a robust network of specialized manufacturing facilities. In Europe, countries such as Germany and the United Kingdom are also significant players, benefiting from strong regulatory frameworks and increasing collaboration between biotech companies and research institutions. Meanwhile, the Asia-Pacific region is emerging rapidly, with countries like China and Japan investing heavily in biotech innovations and expanding their manufacturing capabilities. For example, China's recent $500 million investment in gene therapy infrastructure reflects its growing focus on becoming a major player in this sector.

Cell and Gene Therapy Manufacturing Services Market- Competitive Landscape:

Key players such as Lonza, Catalent, and WuXi AppTec dominate the market with extensive manufacturing capabilities and global reach, providing a range of services from cell processing to gene editing. These companies are bolstered by significant investments in cutting-edge technologies and strategic partnerships. For instance, Lonza's collaboration with Novartis to enhance manufacturing capacity for CAR-T cell therapies highlights the trend towards deepening industry alliances. Emerging biotech firms and contract manufacturing organizations (CMOs) also play a crucial role, offering specialized services and driving innovation. The competitive environment is characterized by continuous advancements in technology, regulatory adaptations, and an emphasis on scalable and efficient manufacturing solutions.

Recent Developments:

In May 2024, ProPharma, in collaboration with PBL, introduced the Cell Factory Box (CF Box), a fully automated and enclosed cell factory device designed for the production of cell and gene therapies (CGTs). The CF Box facilitates decentralized manufacturing of various CGTs within Class D (ISO8) or controlled, non-classified environments.

In May 2024, Bristol Myers Squibb signed a USD 380 million deal with Cellares to produce CAR T-cell therapies, highlighting the rising demand for outsourced cell and gene therapy manufacturing services. Cellares plans to expand its automated manufacturing units in the US, Europe, and Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Adaptimmune Therapeutics plc

Bluebird Bio, Inc.

Catalent, Inc.

Celyad Oncology SA

Charles River Laboratories International, Inc.

Gene Therapy Research Group

Kiadis Pharma N.V.

Lonza Group AG

MaxCyte, Inc.

Miltenyi Biotec GmbH

Orchard Therapeutics plc

Rocket Pharmaceuticals, Inc.

Sangamo Therapeutics, Inc.

Sarepta Therapeutics, Inc.

TCR2 Therapeutics Inc.

WuXi AppTec

Others

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell Therapy
  • Gene Therapy

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Cells
  • Allogeneic Cells

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Contract Development and Manufacturing Organization (CDMO)
  • Contract Research Organization (CRO)
  • Manufacturing Technology Solutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutions
  • Research Institutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell and Gene Therapy Manufacturing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell and Gene Therapy Manufacturing Services Market Snippet by Therapy Type
    • 2.1.2. Cell and Gene Therapy Manufacturing Services Market Snippet by Cell Type
    • 2.1.3. Cell and Gene Therapy Manufacturing Services Market Snippet by Service Type
    • 2.1.4. Cell and Gene Therapy Manufacturing Services Market Snippet by End-User
    • 2.1.5. Cell and Gene Therapy Manufacturing Services Market Snippet by Country
    • 2.1.6. Cell and Gene Therapy Manufacturing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell and Gene Therapy Manufacturing Services Key Market Trends

  • 3.1. Cell and Gene Therapy Manufacturing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell and Gene Therapy Manufacturing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell and Gene Therapy Manufacturing Services Market Opportunities
  • 3.4. Cell and Gene Therapy Manufacturing Services Market Future Trends

4. Cell and Gene Therapy Manufacturing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell and Gene Therapy Manufacturing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell and Gene Therapy Manufacturing Services Market Landscape

  • 6.1. Cell and Gene Therapy Manufacturing Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell and Gene Therapy Manufacturing Services Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
    • 7.1.2. Cell Therapy
    • 7.1.3. Gene Therapy

8. Cell and Gene Therapy Manufacturing Services Market - By Cell Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 8.1.2. Autologous Cells
    • 8.1.3. Allogeneic Cells

9. Cell and Gene Therapy Manufacturing Services Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 9.1.2. Contract Development and Manufacturing Organization (CDMO)
    • 9.1.3. Contract Research Organization (CRO)
    • 9.1.4. Manufacturing Technology Solutions

10. Cell and Gene Therapy Manufacturing Services Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Institutions
    • 10.1.5. Research Institutions

11. Cell and Gene Therapy Manufacturing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cell and Gene Therapy Manufacturing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptimmune Therapeutics plc
    • 12.2.2. Bluebird Bio, Inc.
    • 12.2.3. Catalent, Inc.
    • 12.2.4. Celyad Oncology SA
    • 12.2.5. Charles River Laboratories International, Inc.
    • 12.2.6. Gene Therapy Research Group
    • 12.2.7. Kiadis Pharma N.V.
    • 12.2.8. Lonza Group AG
    • 12.2.9. MaxCyte, Inc.
    • 12.2.10. Miltenyi Biotec GmbH
    • 12.2.11. Orchard Therapeutics plc
    • 12.2.12. Rocket Pharmaceuticals, Inc.
    • 12.2.13. Sangamo Therapeutics, Inc.
    • 12.2.14. Sarepta Therapeutics, Inc.
    • 12.2.15. TCR2 Therapeutics Inc.
    • 12.2.16. WuXi AppTec
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Therapy Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Therapy Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Service Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Service Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cell and Gene Therapy Manufacturing Services Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Therapy Type segment market share analysis, 2023 & 2032
  • FIGURE Therapy Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Cell Type segment market share analysis, 2023 & 2032
  • FIGURE Cell Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Service Type segment market share analysis, 2023 & 2032
  • FIGURE Service Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Germany Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE India Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Brazil Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)